Biliary Adenofibroma of Liver
Thomas Arnason(Dalhousie University), Gregory Y. Lauwers(Moffitt Cancer Center), Catherine E. Hagen(Massachusetts General Hospital), Christopher L. Corless(Oregon Health & Science University), Hala R. Makhlouf(National Cancer Institute), Tania Zuluaga Toro(University of Florida), A. John Iafrate(Massachusetts General Hospital), Joseph Misdraji(Yale University), Heidi Sapp(Queen Elizabeth II Health Sciences Centre), Ian R. Wanless(Toronto General Hospital), Darrell R. Borger(Massachusetts Eye and Ear Infirmary), Wilson M. S. Tsui(Caritas Medical Centre)
Cited by 42
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k